Scarica l'app Stockscreener
0.9049
1.59%
-0.0146
Dopo l'orario di chiusura:
.92
0.0151
+1.67%
Nautilus Biotechnology Inc Borsa (NAUT) Ultime notizie
Nautilus Biotechnology urges new methods to address biological validation challenge in proteomics - Traders Union
Nautilus (NAUT) Watch: Closes 5.82% Higher at $0.90; Technical View: Traders Can Monitor the $0.85-$0.95 Range for the Current SessionSystematic Flow - vinanet.vn
Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Sees Significant Increase in Short Interest - MarketBeat
Nautilus Biotechnology Earnings Call Balances Promise and Risk - TipRanks
NAUT Q2 2026 Earnings: Narrower Loss Surprise Lifts Shares 22%Earnings Deceleration Risk - vinanet.vn
Perceptive Advisors group reports 9.1% Nautilus (NAUT) ownership in updated 13D/A - Stock Titan
Nautilus Biotechnology (NAUT) Slides 3.9% to $0.86, Approaching Key Support LevelLiquidity Order Flow - vinanet.vn
Nautilus Biotechnology (NAUT) Steadies Near $0.89 as Support HoldsUpthrust Pattern - vinanet.vn
Nautilus Biotechnology Inc (NASDAQ: NAUT) Share Price, NAUT Stock News, NAUT Share Price & Updates - Kalkine
Nautilus Biotechnology (NAUT) Institutional Ownership 2026 - MarketBeat
Nautilus Biotechnology unveils new proteomics approach for dementia studies - Traders Union
Nautilus Biotechnology: A Contrarian Proteoformics Play After Recent Pullback (NAUT) - Seeking Alpha
Nautilus Biotechnology, Inc. Revenue Breakdown – NASDAQ:NAUT - TradingView
Short Interest in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Rises By 74.6% - MarketBeat
Nautilus Biotechnology sets 31 July deadline for Iterative Mapping Grant Program applications - tradersunion.com
Nautilus Biotechnology Inc (NAUT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Nautilus Biotechnology, Inc. 2026: Revenue $190K, EPS ($0.11) — 10-Q Summary - tradingview.com
Nautilus Biotechnology Q2 Earnings Call Highlights - Yahoo Finance
Earnings call transcript: Nautilus Biotechnology beats Q2 2026 EPS forecast - Investing.com
Nautilus Biotechnology Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Nautilus Biotechnology posts first revenue, Q2 net loss narrows - TradingView
Nautilus Biotechnology (NASDAQ: NAUT) shifts roadmap after Q2 2026 results - Stock Titan
Nautilus Biotechnology Reports Second Quarter 2026 Financial Results - Yahoo Finance
Nautilus Biotechnology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
NAUT|Nautilus Biotechnology Inc|Price:0.977|Chg%:-0.053 - TradingKey
Nautilus Biotechnology reports Q2 2026: $0.2M revenue, $14.5M net loss, $129.2M cash - TradingView
Nautilus Biotechnology Reports $190,000 Revenue in Second Quarter 2026 - Quiver Quantitative
Nautilus Biotechnology (NAUT) Plunges 25%: Key Levels to Watch After Steep DeclineThrowback Trade - dars.gov.et
Price to earnings forward of Nautilus Biotechnology, Inc. – NASDAQ:NAUT - TradingView
Nautilus Biotechnology Inc (NAUT) Cash Flow - TradingKey
Nautilus Biotechnology Inc (NAUT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
NAUT|Nautilus Biotechnology Inc|Price:1.690|Chg%:-0.080 - TradingKey
Nautilus Biotechnology Inc (NAUT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
NAUT|Nautilus Biotechnology Inc|Price:0.980|Chg%:-0.005 - TradingKey
Nautilus Biotechnology Inc (NAUT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Nautilus Biotechnology Inc (NAUT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
NAUT|Nautilus Biotechnology Inc|Price:1.670|Chg%:-0.020 - TradingKey
Nautilus Biotechnology Inc (NAUT) Risk Assessment: Volatility, Financial Risk & Investment Risk - tradingkey.com
Nautilus Biotechnology Inc (NAUT) Institutional Confidence - TradingKey
TradingKey - TradingKey
Nautilus Biotechnology Inc expected to post a loss of 13 cents a shareEarnings Preview - TradingView
Nautilus Biotechnology (NAUT) to Post Earnings on Tuesday - MarketBeat
Nautilus Biotechnology invites project proposals for Tau Proteoforms Assay grant program - Traders Union
Nautilus Biotechnology (NAUT) Surges 6.1%: Breakout Above Key Support Zone Triggers Buying MomentumCTA Positioning - dars.gov.et
Nautilus Biotechnology2026 Funding Rounds & List of Investors - Tracxn
Nautilus Biotechnology (NAUT) Stages a Recovery: Can the Breakout Hold?Bullish Percent Index - vinanet.vn
Nautilus Biotechnology (NAUT) Posts Modest Decline as Shares Hover Near Support ZoneTrade Entry Signals - vinanet.vn
Nautilus Biotechnology And 2 Promising Penny Stocks To Consider - Sahm
Nautilus Biotechnology (NAUT) Holds Steady Near Support as Biotech Sector Faces Mixed SentimentOBV Divergence - dars.gov.et
Nautilus Biotechnology to present single molecule proteomics webinar on Voyager Platform - Traders Union
Nautilus Biotechnology to announce Q2 2026 results on July 28 - scanx.trade
Nautilus Biotechnology to Announce Second Quarter 2026 Financial Results on July 28, 2026 - Investing News Network
Enterprise value to EBIT forward of Nautilus Biotechnology, Inc. – NASDAQ:NAUT - TradingView
Price to book forward of Nautilus Biotechnology, Inc. – NASDAQ:NAUT - TradingView
Price to sales forward of Nautilus Biotechnology, Inc. – NASDAQ:NAUT - TradingView
Enterprise value to revenue forward of Nautilus Biotechnology, Inc. – NASDAQ:NAUT - TradingView
Nautilus Biotechnology event to reveal new Iterative Mapping method for scientific clarity - Traders Union
Nautilus Biotechnology Appoints Amber Faust Vice Pres of Global Sales >NAUT - Moomoo
Nautilus Biotechnology (NAUT) Faces Pressure as Shares Decline Nearly 6%Head and Shoulders - dars.gov.et
Nautilus Biotechnology (NAUT) Slides 1.6%, Hovering Near Support LevelsLow Vol ETF - DonanımHaber
Form 13D/A Nautilus Biotechnology For: 30 June By Investing.com - Investing.com Nigeria
Andreessen Horowitz trims Nautilus (NAUT) stake in June 2026 block trade - Stock Titan
Nautilus Biotechnology, Inc.(NasdaqCM:NAUT) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
Nautilus Biotechnology, Inc.(NasdaqCM: NAUT) added to Russell 2500 Growth Benchmark - marketscreener.com
Nautilus Biotechnology, Inc.(NasdaqCM: NAUT) added to Russell 2000 Index - marketscreener.com
Nautilus Biotechnology, Inc.(NasdaqCM: NAUT) added to Russell 2000 Value Benchmark - marketscreener.com
Nautilus Biotechnology, Inc.(NasdaqCM:NAUT) added to Russell Microcap Value Benchmark Index - marketscreener.com
0.86%
0.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):